AviadoBio’s $80 Million Series A Financing

Bristows advised AviadoBio’s seed investors.AviadoBio raised $80 million in Series A financing to advance neurodegenerative gene therapy platform. AviadoBio is a pioneering gene therapy company focused on…

This content is for Standard 1 Year members only.
Login Join Now
Giulia Di Palma

Author: Giulia Di Palma

This content is for Standard 1 Year members only.
Login Join Now